282 related articles for article (PubMed ID: 18694401)
1. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience.
Rajani R; Melin T; Björnsson E; Broomé U; Sangfelt P; Danielsson A; Gustavsson A; Grip O; Svensson H; Lööf L; Wallerstedt S; Almer SH
Liver Int; 2009 Feb; 29(2):253-9. PubMed ID: 18694401
[TBL] [Abstract][Full Text] [Related]
2. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome.
Ulrich F; Pratschke J; Neumann U; Pascher A; Puhl G; Fellmer P; Weiss S; Jonas S; Neuhaus P
Liver Transpl; 2008 Feb; 14(2):144-50. PubMed ID: 18236386
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Haagsma EB; Kuipers EJ; Janssen HL
Am J Gastroenterol; 2006 Jan; 101(1):83-90. PubMed ID: 16405538
[TBL] [Abstract][Full Text] [Related]
4. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
5. [Budd-Chiari syndrome and TIPS--twelve years' experience].
Safka V; Hůlek P; Krajina A; Dulícek P; Fejfar T; Jirkovský V; Pozler O; Vańásek T
Cas Lek Cesk; 2005; 144 Suppl 3():38-42. PubMed ID: 16335262
[TBL] [Abstract][Full Text] [Related]
6. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
[TBL] [Abstract][Full Text] [Related]
7. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.
Rössle M; Olschewski M; Siegerstetter V; Berger E; Kurz K; Grandt D
Surgery; 2004 Apr; 135(4):394-403. PubMed ID: 15041963
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.
Zeitoun G; Escolano S; Hadengue A; Azar N; El Younsi M; Mallet A; Boudet MJ; Hay JM; Erlinger S; Benhamou JP; Belghiti J; Valla D
Hepatology; 1999 Jul; 30(1):84-9. PubMed ID: 10385643
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
Attwell A; Ludkowski M; Nash R; Kugelmas M
Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
[TBL] [Abstract][Full Text] [Related]
10. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management.
Rautou PE; Moucari R; Escolano S; Cazals-Hatem D; Denié C; Chagneau-Derrode C; Charpignon C; Lédinghen Vd; Grenouillet-Delacre M; Habersetzer F; Nousbaum JB; Denninger MH; Valla DC; Plessier A
Am J Gastroenterol; 2009 May; 104(5):1140-6. PubMed ID: 19337247
[TBL] [Abstract][Full Text] [Related]
11. Etiology based prevalence of Budd-Chiari syndrome in eastern India.
De BK; De KK; Sen S; Biswas PK; Das TK; Das S; Hazra B
J Assoc Physicians India; 2000 Aug; 48(8):800-3. PubMed ID: 11273472
[TBL] [Abstract][Full Text] [Related]
12. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
Cruz E; Ascher NL; Roberts JP; Bass NM; Yao FY
Clin Transplant; 2005 Aug; 19(4):501-6. PubMed ID: 16008595
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres.
Mentha G; Giostra E; Majno PE; Bechstein WO; Neuhaus P; O'Grady J; Praseedom RK; Burroughs AK; Le Treut YP; Kirkegaard P; Rogiers X; Ericzon BG; Hockerstedt K; Adam R; Klempnauer J
J Hepatol; 2006 Mar; 44(3):520-8. PubMed ID: 16427719
[TBL] [Abstract][Full Text] [Related]
14. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.
Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Hopmans JA; Haagsma EB; van Hoek B; Hansen BE; Rosendaal FR; Janssen HL
Hepatology; 2004 Feb; 39(2):500-8. PubMed ID: 14768004
[TBL] [Abstract][Full Text] [Related]
15. [Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases].
Cobo F; Cervantes F; García-Pagán JC; Bosch J; Rozman C; Montserrat E
Med Clin (Barc); 1996 Nov; 107(17):660-3. PubMed ID: 9064408
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
Darwish Murad S; Luong TK; Pattynama PM; Hansen BE; van Buuren HR; Janssen HL
Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
[TBL] [Abstract][Full Text] [Related]
18. Primary Budd-Chiari syndrome - a single center experience.
Raszeja-Wyszomirska J; Mieżyńska-Kurtycz J; Marlicz W; Lawniczak M; Wójcicki M
Hepatogastroenterology; 2012 Sep; 59(118):1879-82. PubMed ID: 22819909
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
Chinnakotla S; Klintmalm GB; Kim P; Tomiyama K; Klintmalm E; Davis GL; Trotter JF; Saad R; Landaverde C; Levy MF; Goldstein RM; Stone MJ
Transplantation; 2011 Aug; 92(3):341-5. PubMed ID: 21659946
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with surgical therapy of Budd-Chiari syndrome].
Rückert JC; Wolff H; Ridwelski K; Rudolph B; Staffa G; Romaniuk P
Zentralbl Chir; 1992; 117(5):282-93. PubMed ID: 1642051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
